Podcasts about rheumatologists

Send us Fan MailIn this episode, we discuss how to recognize and manage Behçet Disease. Written by Dr. Oswald Chan (Internal Medicine Resident). Reviewed by Dr. Alexa Smith, (Rheumatologist) and Dr. Allen Tran, (General Internist).Support the show

What does it actually cost when a doctor writes a verbal order over the phone instead of seeing the patient? Scott Middleton has the receipts — and the answer is going to make you rethink everything about how American healthcare spends its money. In this episode of The Disrupted Podcast, Scott announces a landmark three-way merger bringing Your Health together with Transitional Care Professionals of America (TCPA) out of Georgia and Providence Care, a hospice organization in South Carolina. The combined organization will serve approximately 55,000 active patients — not patients on a list, but people being seen regularly — and Scott lays out exactly how he's going to run it. What you'll hear in this episode: Why Scott's family owning 80% of the merged company changes everything about how decisions get made — and who they get made for The difference between fee-for-service and value-based care, and why the ACO model means every unnecessary hospitalization literally comes out of Your Health's pocket How Your Health's risk-adjustment-based visit model (16 visits per year per risk point) was independently validated by a new government study — and why it works The three things Scott is asking every new employee to do in the first weeks: align with a nurse practitioner, track every minute of care management, and recruit like their livelihood depends on it — because it does Why Scott's new management philosophy is six words: "Keep them out of the hospital and see your damn patients" This isn't a corporate announcement. It's a playbook for how healthcare can actually work when operators run the company, providers see their patients, and every minute of care gets counted. www.YourHealth.Org

What if the cure for physician burnout isn't a wellness workshop but a 10-minute exercise you can do alone in a quiet room? Brian Sayers is a rheumatologist in Austin, Texas, with nearly 40 years in private practice who founded an anonymous counseling program that has funded almost 4,000 visits for fellow physicians. In this episode, based on his KevinMD article "Finding meaning in medicine: Reconnecting with your childhood calling," he makes a case that reconnecting with your origin story in medicine can realign you with the purpose you may have lost under paperwork, frustration, and systemic pressure. You will hear how he traces his own calling back to a homemade doctor's smock his mother sewed him as a child, how watching physicians care for his dying father shaped his vision of what a doctor should be, and why he asks physicians in small groups to write and share the moment they first wanted to practice medicine. He also tackles the controversy around calling medicine a "calling" and whether that language enables exploitation. If your daily practice no longer resembles the dream that launched it, this conversation will remind you where to look. Tune into our episode "2026 Cholesterol Guidelines: LDL goals, lipoprotein(a), and coronary calcium scoring," brought to you by Novartis Pharmaceuticals Corporation. For the first time in eight years, LDL cholesterol goals have changed, and preventive cardiologist Seth Baum says the new guidelines are a long-overdue course correction. He breaks down the new LDL targets for your highest-risk patients, why the LDL hypothesis should be retired in favor of the LDL fact, why lipoprotein(a) screening finally belongs in every patient's workup, what a coronary calcium score over 300 really means for how aggressively you treat, and how to talk to statin-skeptical patients without losing their trust. Listen now at KevinMD.com/cholesterol. VISIT SPONSOR → https://kevinmd.com/cholesterol Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Today's guest is Dr. Kimti Kumar, a rheumatologist living in New Zealand and completing her PHD at the University of Adelaide. Dr. Kumar's research caught my attention for its focus on non-drug strategies to address the significant challenges faced by scleroderma patients with Raynaud's. As many of you know, I'm always drawn to more holistic approaches to health, and I think you'll find this conversation very insightful. 

Integrative rheumatologist Dr. Aly Cohen combines conventional rheumatology medications with lifestyle and environmental health approaches to manage autoimmune disease, emphasizing nutrition, sleep, exercise, the gut microbiome, and reducing exposure to synthetic chemicals, pesticides, and contaminated water. They discuss how immunosuppressive drugs can be lifesaving but carry infection risks, and how “risk mitigation” and anti-inflammatory dietary patterns can support resilience. Cohen highlights vitamin D's importance in autoimmunity and COVID outcomes and lists four foundational supplements: a clean multivitamin (including iodine), vitamin D3 guided by blood levels, a quality probiotic, and omega-3 fish oil with adequate EPA+DHA; they also cover cautious use of curcumin, limited enthusiasm for glucosamine/chondroitin, and a measured view of collagen. Cohen promotes her hybrid Smart Human Health Summit on women's health (Saturday, April 25), featuring clinicians speaking on menopause/HRT, dementia, cardiology, endocrinology, GLP-1s, and toxins, with in-person, virtual, and recorded access.

In this episode, Dr. Richard Bryan, a rheumatologist at the Medical Group at Montefiore St. Luke's Cornwall, sheds light on the important role of a rheumatologist in diagnosing and treating joint pain. Discover how rheumatologists view joint pain as more than just discomfort, and learn about its potential connections to systemic issues. This information is crucial for anyone experiencing unexplained joint pain or stiffness. Don't forget to subscribe and explore more at SLCMedGroup.com!  Learn more about Dr. Richard Bryan 

Autoinflammatory diseases are often considered rare — but, in clinical practice, they may be far more common than we think. In this episode of Around the Rheum, hosts Dr. Daniel Ennis and Dr. Janet Pope speak with Dr. Jason An, a Toronto rheumatologist with expertise in autoinflammatory disorders.Together, they explore how these conditions differ from classic autoimmune disease, why adult rheumatologists should be thinking about them more often, and how to approach diagnosis when the presentation doesn't fit neatly into familiar categories.Dr. An also shares practical strategies for recognizing autoinflammatory patterns, interpreting genetic testing, and using targeted therapies both diagnostically and therapeutically.In this episode we discuss:The evolving definition of autoinflammatory disease and how it differs from autoimmune diseaseWhy these disorders are not just pediatric diseases and may present in adulthoodA practical cytokine-based framework for classifying autoinflammatory diseasesThe four major inflammatory “buckets”:IL-1–mediated diseasesIL-18-mediated diseasesTNF / NF-κB pathway disordersInterferonopathiesClinical pattern recognition in patients with recurrent fevers and systemic inflammationThe role and limitations of genetic testing in autoinflammatory diseaseWhy variants of uncertain significance (VUS) may still be clinically meaningful in adultsUsing targeted therapies as diagnostic tools (colchicine, IL-1 blockade, JAK inhibitors)When rheumatologists should consider referral to an autoinflammatory disease specialistRecommended reading:Dr. An's review on autoinflammatory diseases in The Journal of Rheumatology:https://www.jrheum.org/content/51/9/848Dr. Jason An, MD, MSc is an adult rheumatologist specializing in the diagnosis and treatment of autoinflammatory diseases who works in community practice in the Greater Toronto Area (GTA)Around The Rheum is produced by the CRA Communications Committee. A special thank you to the podcast team, Dr. Dax G. Rumsey (CRA Communications Committee Chair), Dr. Daniel Ennis (Host), Dr. Janet Pope (Host) David McGuffin (exploreproductions.ca), and Erin Stewart (CRA) for leading production.Our theme music was composed by Aaron Fontwell.For more on the work of the Canadian Rheumatology Association, visit rheum.ca

I'm excited to welcome back Dr. Elizabeth Volkmann. Dr. Volkmann takes a truly holistic approach to care, focusing on the whole person rather than just the disease. She also has a wonderful new Instagram page filled with helpful, informative content that you won't want to miss. As always, it was an absolute delight talking with her.

In this week's episode we interview Joseph Parambil, MD, staff member in the department of pulmonary, allergy and critical care medicine at Cleveland Clinic, about the current challenges of interstitial lung disease, or ILD. ·        Intro by Adam J. Brown, MD 0:12 ·        Welcome back Joseph Parambil, MD 0:32 ·        But first, some medical history on ILD 1:04 ·        ILD vs. IPF 2:26 ·        A quick aside into silicosis and bleomycin 4:27 ·        Trying to describe pulmonary fibrosis 5:23 ·        The different types of ILD 9:44 ·        Finding a slow progression of disease and autoimmune conditions 10:59 ·        Pulmonary fibrosis diagnoses in 1963 14:41 ·        The modern era of ILD 16:22 ·        Nonspecific interstitial pneumonia 20:12 ·        Handing things over to Dr. Parambil 23:01 ·        Helping rheumatologists understand ILD/The alphabet soup 24:34 ·        The shift from biopsies and using immunosuppression 33:07 ·        Is the workup similar for UIP and NSIP? 35:26 ·        Is there a standard protocol for workup in terms of serologies? 36:30 ·        The danger of choosing the wrong treatment 38:43 ·        Immunosuppression in patients with pulmonary hypertension and ILD 40:52 ·        UIP and ANCA vasculitis 42:12 ·        Compared to ten years ago, how are we doing with treatments? 43:10 ·        Where are we with lung transplants? 50:49 ·        Looking at hematopoietic stem cell transplants 53:24 ·        The importance of early diagnosis 54:14 ·        Antifibrotic medicines 56:15 ·        Chronic and acute interstitial lung diseases 58:41 ·        Thank you, Dr. Parambil 1:03:54 ·        A conclusion from Dr. Brown 1:04:20 ·        Thank you for listening 1:04:55 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. Joseph Parambil, MD, is a staff member in the Respiratory Institute and the director of the HHT Center of Excellence and the Vascular Anomalies Center at the Cleveland Clinic. He is associate professor of medicine at Cleveland Clinic's Lerner College of Medicine. He is certified by the American Board of Internal Medicine with additional specialty certification in pulmonary medicine and critical care medicine. References: Homolka J. CMAJ. 1987;PMID:3315158 Liebow A, et al.  : "Frontiers of Pulmonary Radiology." The interstitial pneumonias, pp. 102-141. 1969. Grune & Stratton. Liebow A, et al. Calif Med. 1969;PMID:PMC1501512 Noble PW, et al. Am J Respir Cell Mol Biol. 2005;doi:10.1165/rcmb.F301 Scadding JG, et al. Thorax. 1967;doi:10.1136/thx.22.4.291 Disclosures: Brown and Parambil report no relevant financial disclosures.

Season FIVE Episode TEN of the Your Story Our Fight® podcast welcomes Dr. Aly Cohen. Dr. Aly Cohen is a board-certified rheumatologist, integrative medicine, and environmental health expert in Princeton, New Jersey, and she educates the public about the harmful toxins in our lives and their impacts on health. She delivers speaker engagements, appears as a guest expert on news outlets and podcasts, and authored the best-selling book, “Detoxify: The Everyday Toxins Harming Your Immune System and How to Defend Against Them” (Simon & Schuster, 2025). She is a published medical author and editor, legal medical expert, and also creates environmental health curricula for schools and physician training programs, such as the Academy of Integrative Health & Medicine, Southern California University of Health Sciences, Andrew Weil Center for Integrative Medicine, and the Susan Samueli Integrative Health Institute at the University of California, Irvine.Dr. Cohen earned her undergraduate degree in medical anthropology and human evolution from the University of Pennsylvania. She completed her medical training at Hahnemann University Hospital School of Medicine in Philadelphia and interned and residency in internal medicine at Beth Israel Medical Center in New York City. She further specialized in rheumatology and autoimmune diseases at Montefiore Hospital/Albert Einstein University Hospital in the Bronx, New York.

Artificial Intelligence is rapidly transforming healthcare.From symptom checkers to diagnostic algorithms and predictive analytics, AI tools are becoming more powerful every year.But can AI actually replace a rheumatologist?In this video, we explore the real role of artificial intelligence in autoimmune care and rheumatology — including:• What AI does well• Where AI falls short• Why autoimmune disease is uniquely complex• The importance of clinical judgment• Pattern recognition vs human nuance• The future of AI-assisted medicineRheumatologic conditions like:• Rheumatoid arthritis• Lupus• Psoriatic arthritis• Ankylosing spondylitisrequire more than lab interpretation. They require context, lived experience, pattern evolution, and understanding the whole patient.AI can:✔️ Analyze large datasets✔️ Recognize imaging patterns✔️ Flag abnormal labs✔️ Support clinical decision-makingBut it cannot:✖️ Replace longitudinal relationships✖️ Interpret subtle symptom evolution✖️ Understand patient goals and preferences✖️ Deliver individualized nuanceThe future likely isn't AI versus physicians.It's AI supporting physicians — while preserving the human expertise required for complex autoimmune disease.If you live with autoimmune disease or are curious about the future of medicine, this is a conversation you need to hear.

Dr. Kam Shojania is a Clinical Professor at the University of British Columbia, Head of Rheumatology at Vancouver General Hospital, and Medical Director of the Mary Pack Arthritis Program. He co-leads the DART Clinic at St. Paul's Hospital, a combined dermatology-rheumatology clinic focused on complex inflammatory skin and connective tissue diseases. Dr. Sheila Au is a Clinical Professor in the Department of Dermatology and Skin Science at the University of British Columbia and a medical dermatologist at St. Paul's Hospital. She co-leads the DART Clinic and specializes in inflammatory and autoimmune skin disease, with a focus on morphology-based diagnosis and collaborative care.

What happens when an Infectious Disease specialist and a Rheumatologist look at the same gut?

Season FIVE Episode EIGHT of the Your Story Our Fight® podcast welcomes Dr. Nya Oglesby. Dr. Nya Oglesby is a lupus survivor who turned her diagnosis into purpose-driven advocacy. Diagnosed as a teenager, she uses her lived experience to educate, empower, and uplift others impacted by lupus. She is pursuing a career in pediatric rheumatology and is committed to closing gaps in care for underserved communities. Her work centers on storytelling, faith, and fighting for patients who deserve to be seen and believed.

Polymyalgia Rheumatica (PMR) is one of the most commonly misunderstood inflammatory conditions—yet it affects thousands of people each year, often suddenly and severely. In this episode, Dr. Isabelle Amigues breaks down exactly what PMR is, why it happens, how it's diagnosed, and how patients can reach full remission. Whether you're newly diagnosed or supporting someone who's struggling, this episode brings clarity, empowerment, and science-backed guidance.Main Topics Covered:What PMR Actually IsClassic Symptoms & PresentationWhy PMR HappensHow PMR Is DiagnosedThe Gold-Standard Treatment PlanThe Risk of Giant Cell Arteritis (GCA)Remission & Long-Term OutlookPatient Empowerment & Next StepsPMR is treatable, remission is possible, and you deserve a life free from pain. The more you understand your body, the more power you have to heal.#UnabridgedMD #PolymyalgiaRheumatica #PMRAwareness #RheumatologyCare #AutoimmuneEducation #InflammatoryArthritis #ChronicPainRelief #HealingWithScience

Dr. Birnbaum also addresses common early fears, including confusion about autoimmune disease and anxiety around immunosuppressive medications, reframing treatment as dialing down an overactive immune response rather than taking away your immune system. Throughout the episode, he encourages self-advocacy, realistic hope, and partnership with your care team, and shares insights from his book“Living well with autoimmune diseases”  A Rheumatologist's Guide to Taking Charge of Your Health. The takeaway is empowering and hopeful: we're living in a “golden era” of RA care, with more effective treatments and real reason to believe a full, meaningful life is possible alongside this diagnosis.Episode at a glance:00:20 Dr. Burnbaum's Background and Passion for Arthritis & Neurology05:19 The Diagnostic Process in Rheumatology08:59 Understanding Inflammatory Arthritis15:22 Explaining Autoimmune Diseases and Inflammation23:11 The Role of Immunosuppressive Therapies28:16 Personalized Treatment Plans in Rheumatology30:50 Understanding Diagnostic Criteria and Nuances31:31 Dealing with Diagnostic Ambiguity32:57 Empowerment Through Patient-Doctor Partnership38:10 Practical Tips for Patient Empowerment46:03 Realistic Hope and Coping Strategies56:34 Concluding Thoughts and ResourcesMedical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today's topic is one I've wanted to discuss for a very long time and one that's particularly troubling to me: calcinosis. I was absolutely thrilled when Dr. Ariane Herrick agreed to join me for this conversation. She is incredibly knowledgeable on the subject and shared such valuable insight and information about this challenging condition. I'm so grateful for her time and expertise

In this episode of the RCP Medicine Podcast, we explore the critical issue of health inequalities during pregnancy and the postpartum period. Joining us is Dr Maria Mouyis, Consultant Physician & Rheumatologist with Specialist Interest in Obstetric Medicine, alongside Dr Vasiliki Thanopoulou, RCP clinical education fellow, Rheumatology/GIM Specialist Registrar. Together, they unpack why pregnancy itself can be a risk factor for health inequality, the findings from the MBRRACE report, and the systemic, cultural, and clinical challenges that impact maternal and neonatal outcomes.From disparities in maternal mortality among ethnic minority groups to the role of unconscious bias and digital exclusion, this conversation highlights practical steps clinicians can take to improve equity in care. We also discuss innovative initiatives such as maternal medicine networks, preconception clinics, and community engagement projects that aim to empower women and reduce adverse outcomes.Whether you're a clinician, policymaker, or advocate, this episode offers actionable insights and resources to help drive change.Resources: UK Obstetric Surveillance System (UKOSS) | UKOSS | NPEUReports | MBRRACE-UK | NPEUSpecial interest groups | British Society for RheumatologyEastern Obstetric Medicine Group: EOMG Meetings | MacDonald Obstetric Medicine SocietyMultidisciplinary Approaches to Maternal Health - elearning for healthcareRacism in pain management causes needless suffering | The BMJFIVEXMORERCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

In this heartfelt episode, Dr. Isabelle Amigues sits down with her patient Elizabeth Anthony to discuss her journey from a high school lupus diagnosis and years of difficult symptoms, to finally finding answers and support at UnabridgedMD. Liz shares her struggles with medications, navigating the healthcare system, and the power of listening to her own intuition—even when others doubted her. Together, they explore what true partnership in care looks like, why feeling heard matters, and how hope and persistence can lead to real healing.If you or someone you love is feeling lost or unheard in their autoimmune journey, this conversation is for you.  Subscribe for more patient stories, expert advice, and hope-driven science.#Lupus #AutoimmuneDisease #PatientStory #Rheumatology #Hope #ChronicIllness #UnabridgedMD #HealingJourney

Some rheumatologists are turning down about half the specialist referrals they receive from GPs in order to provide adequate treatment for their existing patients. Ruth Hill reports.

Today's guest is Dr. Kathryn Torok, a pediatric rheumatologist at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh, where she directs the Pediatric Craniofacial Scleroderma Clinic. Scleroderma in children is rare, about five in 100,000 develop localized disease, and only about one in a million develop systemic disease. It's crucial to treat to target as early as possible. I learned so much from Dr. Torok about how scleroderma affects children and the best approaches to care.

Early action changes everything. In this episode, Dr. Isabelle Amigues breaks down exactly how timely diagnosis, clear treatment goals, and a physician who actually listens can move patients from painful flares to true remission—without living on steroids. Topics Covered:Why Speed Matters: The “early window” in inflammatory arthritis (e.g., RA) leads to faster remission, fewer erosions, and better long-term outcomes.What Remission Really Means: No joint pain/swelling,

Dr. Irene Blanco, Rheumatologist at Northwestern Medicine, joins Lisa Dent to discuss autoimmune diseases and how they disproportionately affect women.

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Guest(s): Day Lennep, M.D., Rheumatologist at Mississippi Arthritis ClinicTopic: Lupus. Types, diagnosing, and treatment options.Email the show: remedy@mpbonline.org. If you enjoy listening to this podcast, please consider contributing to MPB. https://donate.mpbfoundation.org/mspb/podcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we sit down with Dr. Kristin to discuss her session at ACR Convergence on taking a personalized approach to pulmonary hypertension in connective tissue diseases. She shares why now is the critical moment for this shift and how “personalized” care extends beyond biomarkers and imaging to encompass clinical nuances, patient-reported symptoms, and multidisciplinary collaboration. We explore the key challenges in detecting pulmonary hypertension early, the promise of emerging technologies like AI-assisted imaging and molecular diagnostics, and the subtle red flags clinicians should recognize in at-risk patients. Dr. Kristin also reflects on her unique dual training in rheumatology and pulmonology, the defining moments that shaped her career, and how mentorship continues to drive innovation and compassion in the care of patients with connective tissue lung disease. 

In this episode, we explore RheumCode, a groundbreaking new initiative from the American College of Rheumatology (ACR) designed to build a common digital language for rheumatology. RheumCode aims to ensure that data means the same thing wherever it lives—whether in an EHR, a clinic, or a registry—enabling systems to seamlessly communicate and make better use of the medical information already being documented. We discussed how RheumCode began, the collaboration behind its development, and its potential to transform the way clinicians practice; researchers study disease, and patients experience their care.  This episode was sponsored by Pfizer  

Welcome to ACR Convergence 2025 in Chicago! Here, Dr. Hausmann delivers a quick update on what our podcasts will cover while the meeting is in session. Don't forget to tune in to ACR on Air and ACR Journals on Air each morning, starting this Saturday, to catch up on the latest in Rheumatology

Today's guest is Dr. Laura Hummers, a rheumatologist and co-director of the Scleroderma Clinic at the Johns Hopkins Scleroderma Center. In our conversation, we dive into the different phenotypes observable characteristics of scleroderma, as well as the three major antibodies commonly found in patients and how they aid in diagnosis. This episode is packed with valuable insights and information you won't want to miss.

How do I keep my LDL low enough without compromising my brain and my liver?I read that fish oil can raise LDL cholesterol. Is this true?A questionable case study on pycnogenol

Reasons for nausea  My PSA was 4.0 six months ago, and now it's up to 4.55. What should I do?I have lupus and need to take Methotrexate. How can I protect my liver and immune system?The important relationship between vitamin D3 and K2

In this episode, Dr. Shaun Jackson uses a compelling patient case to illuminate the complex mechanisms of immune tolerance and autoimmunity. He explains how B cells learn to avoid targeting the body's own tissues through central and peripheral tolerance—and how these safeguards can fail. The discussion covers the roles of germinal centers, T cells, and rare genetic disorders in shaping immune regulation, with Alport's syndrome and post-transplant Goodpasture's disease serving as striking examples. Dr. Jackson also reflects on emerging directions in autoimmune research and shares his journey from medical training in South Africa to leading a research program in Seattle, offering valuable insights for future physician-scientists. 

Rheumatologist and environmental health expert Dr. Aly Cohen reveals a shocking truth: we're all toxic until proven otherwise. From the outdated 1974 Safe Drinking Water Act to the 10,000+ untested chemicals in our food supply, she explains why our bodies are fighting an uphill battle against chronic inflammation. But here's the reality—you don't need to wait for government regulation to start making changes that matter. Dr. Cohen walks through high-yield, actionable changes anyone can make: reverse osmosis water filtration that's cheaper than you think, frozen USDA organic foods that democratize nutrition, and simple swaps that cut chemical exposure without breaking the bank. You'll walk away understanding that your immune system isn't broken—it's just overwhelmed—and you have way more control than you realize. IN THIS EPISODE WE'LL: Discover when to test and when to act—Dr. Cohen explains why everyone's toxic until proven otherwise, and which changes matter most right now Learn the one federal regulation that actually protects your food and how frozen USDA organics give you pesticide-free nutrition at a fraction of the cost Break down why your tap water is likely contaminated regardless of where you live, and how a $400 reverse osmosis system can save you money compared to carbon filters Expose how dust in your home concentrates chemicals from flame retardants, fragrances, and everyday products—plus the simple cleaning methods that actually work Transform your approach to inflammation by understanding how everyday chemical exposures mimic hormones, disrupt immune signaling, and drive everything from breast implant illness to autoimmune disease Let's Connect Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?t=8oQyjO25X5i&r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article - https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

In this week's episode, we dive into the ins and outs of the rheumatology musculoskeletal ultrasound certification process—what it takes to log 150 scans, meet CME requirements, and ultimately sit for the exam. We're joined by Dr. Liudmila Kastsianok, who shares her insights on how ultrasound is reshaping clinical practice, from enhancing diagnostic accuracy to opening new avenues in research. We also explore how incorporating ultrasound into routine care can deepen the physician-patient relationship and improve communication. Finally, Dr. Kastsianok offers her perspective on where the field is headed and why ultrasound is becoming an essential skill for the next generation of rheumatologists. 

In this episode, our guests Dr. Sabrina Hoa and Dr. Marie Hudson explore new insights into late-onset interstitial lung disease (ILD) in scleroderma. Using data from the Canadian Scleroderma Research Group, they discuss how ILD can still develop years after diagnosis, challenging traditional screening timelines. They cover key findings, clinical implications, treatment patterns, and the need for more inclusive trials. The conversation also touches on mentorship and what's next in scleroderma research. 

Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 4: Rheum + Pulm Collaborations in ILD including The Rheumatologist and Pulmonologist: Different approaches to the same patient (Dr. Paul Dellaripa and Dr Rachel Putman).

In this episode, we preview ACR Convergence 2025 in Chicago this October with Dr. Greg Gardner, Chair of the Annual Meeting Planning Committee (AMPC). We'll explore key topics like emerging therapies, AI in rheumatology, and highlights such as the Practice Innovation Summit, Ultrasound Course, and Fellows In Training (FiT) Program. Dr. Gardner also discusses highlights such as, CAR T-cell therapies, new non-renal lupus guidelines, a Live Journals Club focused on Big Data and why this year's meeting is earlier on the calendar. Tune in for a sneak peek at what's to come! 

Today's guest is rheumatologist Dr. Jessica Gordon. Together, we explore two topics that every scleroderma patient is familiar with skin and Raynaud's.Dr. Gordon explains the three stages of skin progression in scleroderma, the challenges patients often face, and the treatments available. We also touch on Raynaud's our discussion may be shorter, but it's filled with helpful insights.I truly enjoyed this conversation with Dr. Gordon, and I know you will too.

In this episode of ACR Journals on Air, host Dr. Vicki Shanmugam speaks with Dr. Alain Sanchez-Rodriguez about a new study from the Lupus Midwest Network (LUMEN), published in Arthritis Care & Research. They explore how patients with systemic lupus erythematosus (SLE) experience delays and disparities in care, the types of physicians involved in diagnosis, and what the data reveals about access to specialized treatment. Dr. Sanchez-Rodriguez also shares his research journey and insights on improving equity in rheumatology. 

It's been over two decades since the American College of Rheumatology (ACR) last released comprehensive treatment guidelines for systemic lupus erythematosus (SLE), and much has changed. In this episode, we're joined by Dr. Lisa Sammaritano to discuss the forthcoming 2025 ACR Guidelines for the Treatment of SLE. These updated recommendations reflect a significant evolution in our approach to lupus care, from the growing range of therapeutic options to a stronger emphasis on patient engagement and minimizing steroid toxicity. We'll dive into how the guidelines tailor treatment across diverse organ systems and patient populations, and what clinicians need to know to effectively incorporate these updates into their practice. 

This episode explores the ARChiVe Registry, a longitudinal database for pediatric vasculitis, with guest Dr. Sam, a pediatric rheumatologist and bioinformatician. The discussion covers the registry's design, patient selection, and key outcomes, including remission rates, hospitalization, and damage scores (pVDI) across treatment strategies. Dr. Sam highlights how these findings inform clinical practice and discusses the challenges of observational data. The episode also touches on his unique background in social pediatrics and health informatics, emphasizing the evolving role of clinicians as both diagnosticians and data stewards in rheumatology research. 

In this episode, we're joined by Karen Durrant, founder of the Autoinflammatory Alliance, who shares her powerful journey from a determined parent seeking a diagnosis for her child to the leader of a global patient advocacy movement. What began as a personal quest has evolved into an international network supporting thousands affected by autoinflammatory diseases. Karen discusses how her collaboration with Dr. Fatma Dedeoglu, a leading pediatric rheumatologist, helped bridge the gap between patient experience and medical research—ultimately contributing to the development of international clinical guidelines that are transforming care for rare disease patients worldwide. 

In this compassionate guide, Dr. Julius Birnbaum offers essential advice for navigating the complex world of various autoimmune diseases. This resource will help patients, caregivers, and health care professionals understand the diagnosis, management, and treatment of conditions like lupus, rheumatoid arthritis, Sjogren's syndrome, and more.

This week, we explore the potential role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with systemic lupus erythematosus (SLE) and comorbid type 2 diabetes (T2D)—a population historically excluded from landmark SGLT2i trials. Our guest, Dr. Karen Costenbader, discusses the rationale behind the study, the nuances of trial emulation design, and key findings regarding cardiovascular and renal outcomes, infection risk, and prescribing patterns in this complex cohort. We also unpack implications for clinical decision-making and the evolving landscape of metabolic and cardiovascular care in autoimmune disease. 

In this episode, we're joined by myositis expert Dr. Brian Feldman to explore Juvenile Dermatomyositis (JDM). We cover its clinical presentation, key diagnostic clues, and the workup including labs and imaging. We examine the MDA5 variant, known triggers, and non-pharmacologic management strategies. Dr. Feldman also addresses the high-stakes scenario of JDM-associated rapidly progressive interstitial lung disease, offering insights into pathophysiology, imaging, and aggressive early treatment. The episode concludes with a look at the field's questions that remain. 

In this engaging episode of the American Glutton Podcast, host Ethan Suplee chats with Dr. Aly Cohen, a rheumatologist and environmental health expert. Dr. Cohen dives into the evolving role of rheumatology, tackling complex conditions like autoimmune diseases and gout. She discusses her book, *Detoxify*, offering practical strategies to reduce exposure to harmful chemicals in food, water, and products. From the benefits of frozen organic produce to her 21-day plan for healthier living, Dr. Cohen emphasizes sustainable changes over perfection. Tune in for insights on navigating the modern food system and improving health without extreme measures.SHOW HIGHLIGHTS00:00 - Introduction to Dr. Aly Cohen 00:18 - What is a Rheumatologist? 01:47 - Gout and Modern Diets 02:58 - Protein and Individualized Nutrition 04:15 - Detoxifying the American Diet 07:12 - Chemicals in Food and Health Impacts 09:28 - Benefits of Frozen Organic Foods 12:16 - Lifestyle and Environmental Health 16:13 - The Four A's Framework 19:54 - Challenges with Extreme Health Approaches 24:31 - Regulatory Failures and Individual Action 27:38 - Obesogens and Weight Gain 32:23 - The 21-Day Detoxify Plan 35:17 - Safer Personal Care Products 42:59 - Water Filtration Solutions 48:54 - Patient Stories and Practical Changes 51:49 - Closing Thoughts and ResourcesEthan Suplee's Substack:https://ethansuplee.substack.com/American Glutton:https://www.americanglutton.net/ Hosted on Acast. See acast.com/privacy for more information.

Today, we explore why naming matters—especially when it comes to peripheral nervous system disorders in autoimmune diseases like Sjögren's. Dr. Shanmugam is joined by Dr. Ghaith Noaiseh and Kathy Hammitt, two key contributors to the recently published manuscript, "Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology," in Arthritis & Rheumatology.  Together, they discuss the critical importance of unified terminology across specialties, the implications for diagnosis and treatment, and how clearer, consistent language can empower both clinicians and patients. The conversation also delves into the development of Clinical Practice Guidelines and how this nomenclature effort supports interdisciplinary care, research, and patient advocacy. Tune in for expert insight and a behind-the-scenes look at a major collaborative effort to bring clarity to complex clinical conversations. 

In this episode, we're joined by Dr. Dana DiRenzo to explore groundbreaking developments in the treatment of Sjögren's Disease. For the first time, therapies like BAFF blockade, CD40 ligand inhibitors, and FcRn antagonists appear poised to change the course of the disease—moving beyond symptom management to potential disease modification. We delve into the underlying science, current clinical trials, and tackle the big question: how early is early enough to begin treatment? Dr. DiRenzo also shares her expert perspective on holistic symptom management through what she calls the "4 Pillars of Health," offering practical strategies for improving quality of life for those living with Sjögren's. 

In this episode of ACR Journals on Air, Dr. Jason Knight joins us to discuss his recent Arthritis & Rheumatology review on antiphospholipid syndrome (APS), an autoimmune disease marked by complex thromboinflammatory processes. We explore the evolving understanding of APS pathogenesis, the role of antiphospholipid antibodies, Beta-2 glycoprotein I, and NETosis, as well as current and emerging treatment strategies. Dr. Knight also shares insights from his research career and reflects on the personal and professional journey behind his work. A must-listen for clinicians and researchers focused on autoimmunity and translational science. 

In this episode, we take the leap from the structured world of rheumatology fellowship into the dynamic, often unpredictable landscape of private practice. Dr. J. Thomas Berry shares his personal journey, offering an honest and insightful look at the transition. From the practical differences between academic and private settings to the business learning curve, patient care dynamics, and how he stays clinically sharp, this conversation is a must-listen for fellows preparing to enter independent practice 

In this episode of Good Nurse Bad Nurse, Tina welcomes physician assistant Joseph Rad, also known as @TheRaddestPA on TikTok! Together, they dive into the malpractice case of Dr. Ian Patterson, who performed unnecessary surgeries, and the fraudulent practices of Dr. Jorge Zamora Quezada, who falsely diagnosed patients for financial gain. The discussion emphasizes the importance of patient advocacy, ethical practices in medicine, and the need for systemic reforms in healthcare. For our "Good Nurse" segment, we're featuring Joseph! Stick around to hear about his journey into social media, highlighting its role in connecting with others during challenging times.   Join us on Patreon to get ad-free episodes, early access, and more exclusive content!   Please support our show by supporting our sponsors below!   Thank you to our sponsor Eko for sponsoring our podcast! Get $50 off your order PLUS a free customizable chestpiece cover when you purchase the CORE 500 Digital Stethoscope using the link ekohealth.com/nurse !